How does the USPTO process Sequence Listing XML files?
The USPTO uses the Sequence Listing Information Control (SLIC) system to process “Sequence Listing XML” files. As stated in MPEP 2419: “At the USPTO, the Sequence Listing Information Control (SLIC) system will be responsible for processing of a ‘Sequence Listing XML’ and exporting the sequence data for publication and grant.” This system ensures that the…
Read MoreWhat are the requirements for submitting a translated “Sequence Listing XML”?
When submitting a translated “Sequence Listing XML”, the following requirements apply: The translation must comply with 37 CFR 1.831 through 1.834. The translated “Sequence Listing XML” should contain English versions of any previously non-English language-dependent free text elements. Updated values for attributes in the root element (37 CFR 1.833(b)(2)(iii)) or elements of the general information…
Read MoreWhat is the significance of the total number of sequences in a “Sequence Listing XML”?
The total number of sequences in a “Sequence Listing XML” is a crucial aspect of the document’s completeness and accuracy. According to MPEP 2412.05(a): “The total number of sequences must be indicated in the ‘Sequence Listing XML’ and must equal the total number of sequence identifiers, whether followed by a sequence or by ‘000’.” This…
Read MoreWhat is the “Title Element” in a Sequence Listing XML?
The “Title Element,” also known as the InventionTitle element, is a required component of the “general information” part of the “Sequence Listing XML” in patent applications. According to MPEP 2413.01(i), this element “need not be in English,” and applicants can provide multiple InventionTitle elements in different languages. To learn more: Sequence Listing XML InventionTitle Patent…
Read MoreHow can I submit a “Sequence Listing XML” file to the USPTO?
There are two methods for submitting a “Sequence Listing XML” file to the USPTO: Via the USPTO patent electronic filing system (currently, XML files can only be submitted via Patent Center) On a read-only optical disc, in compliance with 37 CFR 1.52(e) It’s important to note that if the size of the “Sequence Listing XML”…
Read MoreHow should the Sequence Listing XML be submitted in a patent application?
MPEP 2415 states that the Sequence Listing XML should be submitted “as a separate part of the specification.” This means it should be a distinct section within the patent application, separate from other parts of the disclosure. The Sequence Listing XML must conform to the requirements set forth in 37 CFR 1.831(a), which defines the…
Read MoreHow do I submit a Sequence Listing XML file for a national stage application?
How do I submit a Sequence Listing XML file for a national stage application? For national stage applications, you can submit the Sequence Listing XML file in one of two ways: With the initial submission: Include the Sequence Listing XML file with your initial submission documents. After the initial submission: Submit the Sequence Listing XML…
Read MoreHow can I submit a replacement “Sequence Listing XML” file to the USPTO?
There are two methods for submitting a replacement “Sequence Listing XML” file to the USPTO: Via the USPTO patent electronic filing system (Patent Center) On a read-only optical disc, if the file size exceeds the upload limit of Patent Center According to MPEP 2414.03: A compliant replacement “Sequence Listing XML” submitted as an XML file…
Read MoreWhat is the significance of the dtdVersion attribute in a Sequence Listing XML?
The dtdVersion attribute is a mandatory element in the root element of a Sequence Listing XML. According to the MPEP, which cites WIPO Standard ST.26, paragraph 43, this attribute represents the “Version of the DTD used to create this file in the format ‘V#_#’, e.g., ‘V1_3’.” The significance of the dtdVersion attribute lies in its…
Read MoreWhat types of sequences must be included in a Sequence Listing XML?
According to MPEP 2412.02, a Sequence Listing XML must include nucleotide and/or amino acid sequences that are disclosed by enumeration of their residues in patent applications. The MPEP cites 37 CFR 1.831(a), which states: “Patent applications disclosing nucleotide and/or amino acid sequences by enumeration of their residues, as defined in paragraph (b) of this section,…
Read More